These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11376606)

  • 41. Syntheses of glucose analogues of E5564 as a highly potent anti-sepsis drug candidate.
    Shiozaki M; Doi H; Tanaka D; Shimozato T; Kurakata S
    Bioorg Med Chem; 2006 May; 14(9):3011-6. PubMed ID: 16403638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells.
    Lohmann KL; Vandenplas M; Barton MH; Moore JN
    J Endotoxin Res; 2003; 9(1):33-7. PubMed ID: 12691616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diastereoselective Synthesis of 3,4-Dihydropyran-3-carboxamides with in Vitro Anti-inflammatory Activity.
    Zeng LY; Xi B; Huang K; Bi J; Wei L; Cai C; Liu S
    ACS Comb Sci; 2019 Oct; 21(10):656-665. PubMed ID: 31433616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of TNF-alpha and MnSOD by endotoxin: effect of E5531, a synthetic non-toxic lipid A analog.
    White JE; Tsan MF
    J Endotoxin Res; 2000; 6(4):329-35. PubMed ID: 11521054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity.
    Kumazawa Y; Takimoto H; Yamamoto A; Homma JY; Ogawa Y; Kiso M; Hasegawa A
    FEBS Lett; 1988 Oct; 239(1):117-20. PubMed ID: 3181417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopharmacological activities of 2-keto-3-deoxyoctonic acid-(alpha 2----6)-linked 4-O-phosphono-D-glucosamine derivatives carrying N- and 3-O-acyl substituents.
    Kumazawa Y; Matsuura M; Homma JY; Furuya T; Takimoto H; Inagaki K; Nagumo T; Kiso M; Hasegawa A
    Infect Immun; 1989 Jun; 57(6):1845-8. PubMed ID: 2785963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Synthesis of lipid A analogs: achievements and perspective].
    Gorbach VI; Solov'eva TF; Ovodov IuS
    Bioorg Khim; 1988 Apr; 14(4):437-52. PubMed ID: 3048269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of lipopolysaccharide-, lipid IVa-, and lipid X-induced tumor necrosis factor production in murine macrophage-like cell lines.
    Birkland TP; Cornwell RD; Golenbock DT; Proctor RA
    Adv Exp Med Biol; 1990; 256():399-402. PubMed ID: 2327296
    [No Abstract]   [Full Text] [Related]  

  • 50. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes.
    Czeslick E; Struppert A; Simm A; Sablotzki A
    Inflamm Res; 2006 Nov; 55(11):511-5. PubMed ID: 17122970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of carbocyclic analogues of lipid X: new nonpolar antagonists of LPS induced TNF production.
    Augy-Dorey S; Billington DC; Camara JA; Gero SD; Sagnard I; Quiclet-Sire B; Ghezzi D
    Drug Des Discov; 1999 Jul; 16(1):41-8. PubMed ID: 10466055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation.
    Müller M; Scheel O; Lindner B; Gutsmann T; Seydel U
    J Endotoxin Res; 2003; 9(3):181-6. PubMed ID: 12831460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interleukin 1 and tumor necrosis factor: studies on the induction by lipopolysaccharide partial structures.
    Flad HD; Loppnow H; Feist W; Wang MH; Brade H; Kusumoto S; Rietschel ET; Ulmer AJ
    Lymphokine Res; 1989; 8(3):235-8. PubMed ID: 2789317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic synthesis and anti-inflammatory activity of ω-carboxylated menaquinone derivatives--Investigations on identified and putative vitamin K₂ metabolites.
    Fujii S; Shimizu A; Takeda N; Oguchi K; Katsurai T; Shirakawa H; Komai M; Kagechika H
    Bioorg Med Chem; 2015 May; 23(10):2344-52. PubMed ID: 25858455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Syntheses of glucose derivatives of E5564-related compounds and their LPS-antagonistic activities.
    Shiozaki M; Iwano Y; Doi H; Tanaka D; Shimozato T; Kurakata S
    Carbohydr Res; 2006 May; 341(7):811-22. PubMed ID: 16530740
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety, pharmacokinetics, pharmacodynamics, and plasma lipoprotein distribution of eritoran (E5564) during continuous intravenous infusion into healthy volunteers.
    Rossignol DP; Wasan KM; Choo E; Yau E; Wong N; Rose J; Moran J; Lynn M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3233-40. PubMed ID: 15328078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
    Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
    J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monophosphoryl lipid A analogues with varying 3-O-substitution: synthesis and potent adjuvant activity.
    Jiang ZH; Budzynski WA; Qiu D; Yalamati D; Koganty RR
    Carbohydr Res; 2007 May; 342(6):784-96. PubMed ID: 17300769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
    Cooke KR; Gerbitz A; Crawford JM; Teshima T; Hill GR; Tesolin A; Rossignol DP; Ferrara JL
    J Clin Invest; 2001 Jun; 107(12):1581-9. PubMed ID: 11413166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.